Nuvalent, Inc. (NUVL)
NASDAQ: NUVL · Real-Time Price · USD
101.94
-2.10 (-2.02%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Nuvalent Market Cap
Nuvalent has a market cap or net worth of $8.01 billion as of April 29, 2026. Its market cap has increased by 80.57% in one year.
Market Cap
8.01B
Enterprise Value
6.64B
1-Year Change
80.57%
Ranking
Category
Stock Price
$101.94
Market Cap Chart
Since the IPO on July 29, 2021, Nuvalent's market cap has increased from $795.96M to $8.01B, an increase of 906.86%. That is a compound annual growth rate of 62.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 8.18B | 4.71% |
| Dec 31, 2025 | 7.81B | 40.44% |
| Dec 31, 2024 | 5.56B | 20.68% |
| Dec 29, 2023 | 4.61B | 174.21% |
| Dec 30, 2022 | 1.68B | 82.83% |
| Dec 31, 2021 | 919.33M | 15.50% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Praxis Precision Medicines | 9.60B |
| Axsome Therapeutics | 9.51B |
| ABIVAX Société Anonyme | 8.90B |
| Vaxcyte | 8.56B |
| Bio-Techne | 8.48B |
| Cytokinetics | 8.12B |
| Krystal Biotech | 8.02B |
| Halozyme Therapeutics | 7.74B |